262 related articles for article (PubMed ID: 37484966)
1. A non-linear relationship between triglyceride glucose waist circumference and nonalcoholic fatty liver disease in a Japanese population: a secondary analysis.
He X; Huang X; Qian Y; Sun T
Front Endocrinol (Lausanne); 2023; 14():1188214. PubMed ID: 37484966
[TBL] [Abstract][Full Text] [Related]
2. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
Li S; Feng L; Ding J; Zhou W; Yuan T; Mao J
BMC Gastroenterol; 2023 Nov; 23(1):376. PubMed ID: 37919650
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
[No Abstract] [Full Text] [Related]
4. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
[TBL] [Abstract][Full Text] [Related]
5. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters.
Xue Y; Xu J; Li M; Gao Y
Front Endocrinol (Lausanne); 2022; 13():951689. PubMed ID: 36120429
[TBL] [Abstract][Full Text] [Related]
6. Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus.
Malek M; Khamseh ME; Chehrehgosha H; Nobarani S; Alaei-Shahmiri F
Endocrine; 2021 Dec; 74(3):538-545. PubMed ID: 34355342
[TBL] [Abstract][Full Text] [Related]
7. Triglyceride Glucose-Waist Circumference Is Superior to the Homeostasis Model Assessment of Insulin Resistance in Identifying Nonalcoholic Fatty Liver Disease in Healthy Subjects.
Kim HS; Cho YK; Kim EH; Lee MJ; Jung CH; Park JY; Kim HK; Lee WJ
J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011784
[TBL] [Abstract][Full Text] [Related]
8. Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients.
Bockarie AS; Nartey YA; Nsiah P; Edzie EKM; Tuoyire D; Acquah S; Eliason S; Nkum B
Endocrinol Diabetes Metab; 2023 Nov; 6(6):e456. PubMed ID: 37814510
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Triglyceride Glucose Index and Modified Triglyceride Glucose Indices to Predict Nonalcoholic Fatty Liver Disease in Youths.
Song K; Park G; Lee HS; Lee M; Lee HI; Choi HS; Suh J; Kwon A; Kim HS; Chae HW
J Pediatr; 2022 Mar; 242():79-85.e1. PubMed ID: 34808224
[TBL] [Abstract][Full Text] [Related]
10. Triglyceride Glucose-Waist Circumference (TyG-WC) Is a Reliable Marker to Predict Non-Alcoholic Fatty Liver Disease.
Song S; Son DH; Baik SJ; Cho WJ; Lee YJ
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140352
[TBL] [Abstract][Full Text] [Related]
11. Baseline level and change trajectory of the triglyceride-glucose index in relation to the development of NAFLD: a large population-based cohort study.
Wang Y; Wang J; Liu L; Yang P; Deng S; Liu X; Zhao L; Wang C; Li Y
Front Endocrinol (Lausanne); 2023; 14():1137098. PubMed ID: 37223043
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
[TBL] [Abstract][Full Text] [Related]
13. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.
Guo W; Lu J; Qin P; Li X; Zhu W; Wu J; Xu N; Zhang Q
Lipids Health Dis; 2020 Oct; 19(1):218. PubMed ID: 33028338
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
[TBL] [Abstract][Full Text] [Related]
15. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients.
Zhao J; Fan H; Wang T; Yu B; Mao S; Wang X; Zhang W; Wang L; Zhang Y; Ren Z; Liang B
Cardiovasc Diabetol; 2022 Jul; 21(1):123. PubMed ID: 35778734
[TBL] [Abstract][Full Text] [Related]
16. Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults.
Lee SB; Kim MK; Kang S; Park K; Kim JH; Baik SJ; Nam JS; Ahn CW; Park JS
Endocrinol Metab (Seoul); 2019 Jun; 34(2):179-186. PubMed ID: 31257745
[TBL] [Abstract][Full Text] [Related]
17. The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
Kitae A; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
Can J Gastroenterol Hepatol; 2019; 2019():5121574. PubMed ID: 31687367
[TBL] [Abstract][Full Text] [Related]
18. Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes.
Li N; Tan H; Xie A; Li C; Fu X; Xang W; Kirim A; Huang X
BMC Endocr Disord; 2022 Apr; 22(1):101. PubMed ID: 35428219
[TBL] [Abstract][Full Text] [Related]
19. Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population.
Zeng P; Cai X; Yu X; Gong L
Sci Rep; 2023 Nov; 13(1):20470. PubMed ID: 37993481
[TBL] [Abstract][Full Text] [Related]
20. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
